Reduction of interval cancer: in aggregate, the MASAI trial observed a large increase in cancer detection (29% increase in ...
Telesurgery (operating on a patient remotely using a surgical robot via a secure telecommunication link) appears to be as ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...
First randomised controlled trial of telesurgery finds it a ‘feasible solution’ for uneven distribution of medical services.
The Pioneer on MSN
Concept Medical enrols first patients in STARS DAPT trial
India, Jan. 25 -- Concept Medical Inc, a global developer of drug-delivery technologies for cardiovascular interventions, has ...
The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...
Surgeons can safely perform two common operations from up to 2,800 kilometres away, the equivalent of a medic in southern ...
The Print on MSN
AI mammograms detect more cancers, cut later diagnoses by 12%—Swedish trial of 1 lakh women
Study involved over 1 lakh women who were randomly assigned to either AI-supported breast cancer screening or standard ...
Achieving 100 enrolled patients in the NIH-funded SEANOBI Expanded-Access Program marks substantial progress in the clinical ...
A study published in The Lancet has found that AI-supported breast cancer screening in Sweden is more effective than standard ...
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results